Autonomic Tech Announces Expanded Indication In Europe (CE Mark) For Disabling Migraine With Pulsante SPG Microstimulator System Post author:Sam Post published:March 9, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like 5 Biotechs Awaiting FDA Decisions in January 2018 December 27, 2017 Hanmi Pharma Charged for Failure to Report Patient Death in Olmutinib Study April 17, 2017 Luminex And Collaborate To Improve Patient Care August 28, 2017